Theophylline Oral Solution
If you find any inaccurate information, please let us know by providing your feedback here

This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
1 DEFINITION
Theophylline Oral Solution contains NLT 95.0% and NMT 105.0% of the labeled amount of theophylline (C7H8N4O2 ).
2 IDENTIFICATION
A. The UV spectrum of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
Procedure
Solution A: 10 mM ammonium acetate prepared as follows. Transfer 771 mg/L of ammonium acetate to a suitable flask, and dissolve in water. Adjust with glacial acetic acid to a pH of 5.4 and dilute with water to volume. Pass through a suitable filter of 0.2-μm pore size.
Solution B: Methanol
Mobile phase: See Table 1.
Table 1
| Time (min) | Solution A (%) | Solution B (%) |
|---|---|---|
| 0 | 93.5 | 6.5 |
| 2.5 | 93.5 | 6.5 |
| 5.0 | 10 | 90 |
| 5.1 | 93.5 | 6.5 |
| 7.0 | 93.5 | 6.5 |
Standard solution: 0.2 mg/mL of USP Theophylline RS in water
Sample solution: Nominally 0.2 mg/mL of theophylline from Oral Solution in water. Centrifuge and use the supernatant.
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 270 nm. For Identi
cation test A, use a photodiode array detector in the range of 210–400 nm.
Column: 2.1-mm × 10-cm; 1.7-μm packing L7
Column temperature: 40 ± 2°
Flow rate: 0.4 mL/min
Injection volume: 1 μL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: NMT 2
Relative standard deviation: NMT 1.0%
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of the labeled amount of theophylline (C7H8N4O2 ) in the portion of Oral Solution taken:
Result = (rU /rS ) × (CS /CU ) × 100
rU = peak response of theophylline from the Sample solution
rS = peak response of theophylline from the Standard solution
CS = concentration of USP Theophylline RS in the Standard solution (mg/mL)
CU = nominal concentration of theophylline in the Sample solution (mg/mL)
Acceptance criteria: 95.0%–105.0%
4 IMPURITIES
Organic Impurities
Solution A, Solution B, Mobile phase, and Chromatographic system: Proceed as directed in the Assay.
Impurity stock solution: 0.1 mg/mL each of USP Theophylline RS and USP Theophylline Related Compound D RS in water
System suitability solution: 10 μg/mL each of USP Theophylline RS and USP Theophylline Related Compound D RS from Impurity stock
solution, and 10 μg/mL of USP Saccharin Sodium RS in water
Standard solution: 2.0 μg/mL each of USP Theophylline RS and USP Theophylline Related Compound D RS from Impurity stock solution in water
Sample solution: Nominally 1.0 mg/mL of theophylline from a portion of Oral Solution in water. Centrifuge and use the supernatant.
System suitability
Samples: System suitability solution and Standard solution
[Note—See Table 2 for relative retention times.]
Suitability requirements
Resolution: NLT 2.0 between theophyllidine and saccharin, System suitability solution
Relative standard deviation: NMT 3.0% for theophylline and theophylline related compound D peaks, Standard solution
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of theophylline related compound D in the portion of Oral Solution taken:
Result = (rU /rS ) × (CS /CU ) × 100
rU = peak response of theophylline related compound D from the Sample solution
rS = peak response of theophylline related compound D from the Standard solution
CS = concentration of USP Theophylline Related Compound D RS in the Standard solution (mg/mL)
CU = nominal concentration of theophylline in the Sample solution (mg/mL)
Calculate the percentage of any other individual unspecified degradation product in the portion of Oral Solution taken:
Result = (rU /rS ) × (CS /CU ) × 100
rU = peak response of any other individual unspecified degradation product from the Sample solution
rS = peak response of theophylline from the Standard solution
CS = concentration of USP Theophylline RS in the Standard solution (mg/mL)
CU = nominal concentration of theophylline in the Sample solution (mg/mL)
Acceptance criteria: See Table 2. Disregard peaks less than 0.1%.
Table 2
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
|---|---|---|
| Theophylline related compound D | 0.45 | 0.2 |
| Saccharina | 0.50 | – |
| Theophylline | 1.0 | – |
| Any other individual unspecified degradation product | – | 0.2 |
| Total impurities | – | 1.0 |
a Included as a potential excipient. Do not include in the calculation of total impurities.
5 SPECIFIC TESTS
Microbial Enumeration Tests 〈61〉andTests for Specified Microorganisms 〈62〉: Meets the requirements of the tests for absence of Salmonella species and Escherichia coli. The total aerobic microbial count does not exceed 1 × 102 cfu/mL, and the total combined molds and yeasts count does not exceed 5 × 101 cfu/mL.
pH 〈791〉: 3.0–4.7
Alcohol Determination 〈611〉, Method II(if present)
Analysis: Use acetone as the internal standard.
Acceptance criteria: 90.0%–115.0% of the labeled amount of alcohol (C2H5OH)
6 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in tight, light-resistant containers, and store at controlled room temperature.
Labeling: Label it to indicate the alcohol content (if present).
USP Reference Standards 〈11〉
USP Alcohol Determination—Acetonitrile RS
USP Alcohol Determination±Alcohol RS
USP Saccharin Sodium RS
USP Theophylline RS
USP Theophylline Related Compound D RS
Theophyllidine;
N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate.
C7H8N4O2 · HCl · H2O

